Nociti, Viviana
 Distribuzione geografica
Continente #
NA - Nord America 5.406
EU - Europa 4.454
AS - Asia 3.682
SA - Sud America 753
AF - Africa 106
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 9
Totale 14.426
Nazione #
US - Stati Uniti d'America 5.291
DE - Germania 1.710
SG - Singapore 1.666
CN - Cina 925
SE - Svezia 751
BR - Brasile 606
FR - Francia 402
IT - Italia 356
UA - Ucraina 355
VN - Vietnam 328
GB - Regno Unito 216
IN - India 172
IE - Irlanda 170
FI - Finlandia 152
ID - Indonesia 122
RU - Federazione Russa 93
JP - Giappone 78
TR - Turchia 71
PL - Polonia 59
HK - Hong Kong 58
IQ - Iraq 50
AR - Argentina 45
BD - Bangladesh 45
CA - Canada 45
BE - Belgio 35
ZA - Sudafrica 35
NL - Olanda 29
MX - Messico 27
AT - Austria 26
CO - Colombia 24
EC - Ecuador 21
VE - Venezuela 20
ES - Italia 19
IR - Iran 19
KR - Corea 18
SA - Arabia Saudita 18
CI - Costa d'Avorio 17
MA - Marocco 15
UZ - Uzbekistan 14
AU - Australia 11
CL - Cile 11
UY - Uruguay 11
AZ - Azerbaigian 10
CH - Svizzera 10
JO - Giordania 10
PK - Pakistan 10
PY - Paraguay 10
IL - Israele 9
JM - Giamaica 8
KE - Kenya 8
MY - Malesia 8
EG - Egitto 7
GR - Grecia 7
RO - Romania 7
A2 - ???statistics.table.value.countryCode.A2??? 6
CR - Costa Rica 6
CZ - Repubblica Ceca 6
DO - Repubblica Dominicana 6
LT - Lituania 6
MD - Moldavia 6
TN - Tunisia 6
BG - Bulgaria 5
BY - Bielorussia 5
NP - Nepal 5
PH - Filippine 5
TT - Trinidad e Tobago 5
BO - Bolivia 4
DZ - Algeria 4
HN - Honduras 4
HU - Ungheria 4
KZ - Kazakistan 4
NO - Norvegia 4
PA - Panama 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BH - Bahrain 3
EU - Europa 3
HT - Haiti 3
NI - Nicaragua 3
OM - Oman 3
PS - Palestinian Territory 3
QA - Qatar 3
AM - Armenia 2
AO - Angola 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
KG - Kirghizistan 2
KH - Cambogia 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
LY - Libia 2
MN - Mongolia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
SY - Repubblica araba siriana 2
Totale 14.404
Città #
Singapore 871
Chandler 758
Ashburn 613
San Jose 551
Jacksonville 249
Ann Arbor 191
San Mateo 178
Dublin 170
Beijing 169
Munich 159
New York 133
Los Angeles 123
Nürnberg 116
Nanjing 115
Ho Chi Minh City 111
Jakarta 111
Wilmington 106
Dearborn 101
Lauterbourg 101
Hanoi 93
Hefei 91
Woodbridge 78
Houston 72
Boston 67
Princeton 62
Helsinki 60
Tokyo 57
Milan 56
Moscow 55
Hong Kong 54
Buffalo 52
Marseille 50
Frankfurt am Main 49
Dallas 48
Rome 48
Chicago 47
Seattle 47
Bremen 45
São Paulo 45
Izmir 44
Norwalk 43
Redwood City 43
Nanchang 41
Lawrence 35
Brussels 33
Santa Clara 33
Cattolica 32
Fairfield 29
Detroit 28
Warsaw 28
Boardman 27
Kent 24
Kraków 24
Mountain View 24
Shanghai 24
Brooklyn 23
Kunming 23
Hebei 22
Rio de Janeiro 22
University Park 22
Atlanta 21
Johannesburg 21
Paris 21
Shenyang 21
Düsseldorf 20
Tianjin 20
Chennai 19
Jiaxing 19
Nuremberg 19
Belo Horizonte 18
Guangzhou 18
Haiphong 18
Abidjan 17
Baghdad 17
Orem 17
Da Nang 16
Seoul 16
Fremont 15
London 15
The Dalles 15
Manchester 14
Portsmouth 14
Pune 14
Turku 14
Council Bluffs 13
Leawood 13
San Francisco 13
Stockholm 13
Vienna 13
Ottawa 12
Redmond 12
Tashkent 12
Zhengzhou 12
Changsha 11
Falls Church 11
Tukwila 11
Amman 10
Baku 10
Jinan 10
Newark 10
Totale 7.331
Nome #
Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis 264
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 253
Optical Coherence Tomography Advanced Parameters in Patients With Multiple Sclerosis: Ophthalmological and Neurological Assessments 252
pSTAT1, pSTAT3, and T-bet as markers of disease activity in chronic inflammatory demyelinating polyradiculoneuropathy. 246
CD8(+) T Cells in Facioscapulohumeral Muscular Dystrophy Patients with Inflammatory Features at Muscle MRI 240
T-bet, pSTAT1 and pSTAT3 expression in peripheral blood mononuclear cells during pregnancy correlates with post-partum activation of multiple sclerosis. 239
T-bet and pSTAT1 expression in peripheral blood mononuclear cells from coeliac disease patients: new markers of disease activity 222
Progressive ascending myelopathy: atypical forms of multiple sclerosis or what else? 198
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis. 194
Multiple Sclerosis attacks triggered by hyperprolactinemia 194
The left parietal lobe plays a role in the pathogenesis of blepharospasm? 188
Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 186
Pneumonia's link with the head and heart. 179
Migraine-like headache and status migrainosus as attacks of Multiple Sclerosis in a child. 178
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 177
Glucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patients. 174
Somatosensory evoked potentials reflect the upper limb motor performance in multiple sclerosis. 173
Circulating CD8+CD56-Perforin+ T cells are increased in Multiple Sclerosis patients 173
Correlations between peripheral blood mononuclear cell production of BDNF, TNF-alpha, IL-6, IL-10 and cognitive performances in multiple sclerosis patients 172
Epstein-Barr virus antibodies in serum and cerebrospinal fluid from Multiple Sclerosis, Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Amyotrophic Lateral 168
Type 1 immune response in progressive Multiple Sclerosis 167
A Case of Hemiabdominal Myoclonus 166
Refractory generalized seizures and cerebellar ataxia associated with anti-GAD antibodies responsive to immunosuppressive treatment. 165
Demyelinating Encephalomyeloradiculitis with Balò-like lesions 164
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 164
Movement disorders in multiple sclerosis: Causal or coincidental association? 162
CD4+pSTAT3+ and CD8+T-bet+ T cells accumulate in peripheral blood during NZB treatment 155
CD8(+)Foxp3(+) T cells in peripheral blood of relapsing-remitting multiple sclerosis patients 152
Serum lactate as a novel potential biomarker in multiple sclerosis 149
Increased CD4(+)CD25(+)Foxp3(+) T Cells in Peripheral Blood of Celiac Disease Patients: Correlation with Dietary Treatment. 148
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 148
Brainstem and spinal cord involvement in a paraneoplastic syndrome associated with anti-Yo antibody and breast cancer. 146
IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis. 146
The Expanding Role of the Infectious Disease Expert in the Context of the MS Centre 145
The persistency of high levels of pSTAT3 expression in circulating CD4+ T cells from CIS patients favors the early conversion to clinically defined multiple sclerosis. 142
Pneumonia's link with the head and the heart 141
Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis 141
Chronic migraine-like headache caused by a demyelinating lesion in the brainstem 139
Depression in multiple sclerosis: effect of brain derived neurotrophic factor Val66Met polymorphism and disease perception 138
Breastfeeding and multiple sclerosis 137
Effects of rehabilitation treatment of the upper limb in Multiple Sclerosis patients and predictive value of neurophysiological measures 137
Sleep and fatigue in multiple sclerosis: A questionnaire-based, cross-sectional, cohort study 136
Severe disability in patients with relapsing-remitting multiple sclerosis is associated with profound changes in the regulation of leptin secretion 135
Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients 134
gc) Increased CD4+CD25+Foxp3+ T cells in peripheral blood of celiac disease patients: correlation with dietary treatment. 133
A Case of Hemiabdominal Myoclonus 133
Glioblastoma in multiple sclerosis: a case report 130
Correlations between peripheral blood mononuclear cell production of BDNF, TNF-alpha, IL-6, IL-10 and cognitive performances in multiple sclerosis patients 129
Tourettism in multiple sclerosis: a case report 126
Teaching NeuroImages: Autosomal dominant leukodystrophy in a sporadic case. 126
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 126
Defining the disease course of TNFα blockers-associated Multiple Sclerosis 125
Expression Profile of Long Non-Coding RNAs in Serum of Patients with Multiple Sclerosis. 124
Coeliac disease presenting with acute disseminated encephalomyelitis. 123
Neurotriphic factor in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy 123
Monophasic demyelinating disease of the central nervous system associated with Hepatitis A infection 122
Case of postpartum Parsonage-Turner syndrome 122
Coeliac disease presenting with acute disseminated encephalomyelitis 119
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 119
Liposome-based nanoparticles impact on regulatory and effector phenotypes of macrophages and T cells in multiple Sclerosis patients 118
Liposome-based nanoparticles impact on regulatory and effector phenotypes of macrophages and T cells in multiple Sclerosis patients 118
CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis 118
Regulatory T cells fail to suppress CD4(+)T-bet(+) T cells in relapsing multiple sclerosis patients 118
Lower urinary tract disorders in multiple sclerosis patients: prevalence, clinical features, and response to treatments 118
The Impact of Neurogenic Lower Urinary Tract Symptoms and Erectile Dysfunctions on Marital Relationship in Men with Multiple Sclerosis: A Single Cohort Study 117
Leptin enhances the release of cytokines by peripheral blood mononuclear cells from relapsing multiple sclerosis patients 117
Multiple sclerosis attacks triggered by hyperprolactinemia 116
Severe dyspnoea with alteration of the diffusion capacity of the lung associated with fingolimod treatment 116
Response to the letter to the Editor for the manuscript “Sleep and Fatigue in Multiple Sclerosis: A questionnaire-based, cross-sectional, cohort study” by Tomoyuki Kawada 114
BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression 114
A unique case of multiphasic ADEM or what else? 114
gc)Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 113
Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report 111
gc) T-bet and pSTAT-1 expression in PBMC from coeliac disease patients: new markers of disease activity. 110
Focal hyperhidrosis in tumefactive Multiple Sclerosis 110
Prevalence of multiple sclerosis in the Lazio region, Italy: use of an algorithm based on health information systems 109
An atypical case of acute disseminated encephalomyelitis associated with cytomegalovirus infection 109
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience 108
Posterior reversible encephalopathy syndrome after intramuscular oxygen-ozone therapy 108
pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity 107
Evidence of involvement of leptin and IL-6 peptides in the action of interferon-beta in secondary progressive multiple sclerosis 107
Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients 107
What do we know about the role of lncRNAs in multiple sclerosis? 107
Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta 106
Correction: BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression(PLoS ONE (2018) 1310 (e0206140) DOI: 10.1371/journal.pone.0206140) 106
MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study 106
In vivo effect of Mitoxantrone on the production of pro- and anti-inflammatory cytokines by peripheral blood mononuclear cells of secondary progressive multiple sclerosis patients 105
Clinical characteristics, course and prognosis of spinal multiple sclerosis 105
Fingolimod vs dimethyl fumarate in multiple sclerosis 104
Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved? 97
COVID-19 presenting as a non-arteritic anterior ischemic optic neuropathy 96
Neurosarcoidosis presenting as longitudinally extensive myelitis: Diagnostic assessment, differential diagnosis, and therapeutic approach 96
Exit strategies for “needle fatigue” in multiple sclerosis: a propensity score-matched comparison study 96
Focal muscle vibration, an effective rehabilitative approach in severe gait impairment due to multiple sclerosis 95
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study 94
Neurologic Urinary Incontinence, Lower Urinary Tract Symptoms and Sexual Dysfunctions in Multiple Sclerosis: Expert Opinions Based on the Review of Current Evidences 91
Identifying Relapses in Multiple Sclerosis Patients through Administrative Data: A Validation Study in the Lazio Region, Italy 91
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis 87
Systematic assessment and characterization of chronic pain in multiple sclerosis patients 86
Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experience 85
Totale 13.857
Categoria #
all - tutte 57.872
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.872


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022959 98 78 18 120 29 38 17 141 48 55 130 187
2022/20232.007 224 283 164 319 121 276 101 183 233 31 53 19
2023/2024907 35 269 26 59 24 122 92 27 21 24 103 105
2024/20251.929 54 67 145 97 124 85 78 99 321 166 381 312
2025/20264.726 775 140 262 518 910 179 763 240 336 339 130 134
2026/202746 46 0 0 0 0 0 0 0 0 0 0 0
Totale 14.589